BWA | JUL 2026 105 plicitly promoted digital scanning with the iTero intraoral scanner, describing it as a workflow enhancer for dental sleep medicine and broader practice efficiency. That link with iTero is especially relevant because it gives the company a tangible technology-partner angle. Digital scanning is not simply a convenience feature here; it supports SomnoMed’s “First Time Fit” proposition, reduces chair time, and helps standardise the front end of a highly customised manufacturing process. In a business built around patient comfort and long-term compliance, getting the fit right quickly is commercially and clinically meaningful. The patient-use data SomnoMed publishes helps reinforce that point. On its physician-facing materials, the company says SomnoDent Avant users average 6.9 hours of nightly use and that 91% report improved sleep quality. Those figures are not a substitute for broader clinical literature, but they are useful as a reflection of how SomnoMed wants the market to understand its core value proposition: not just efficacy on paper, but real-world adherence. There is also a commercial-education layer to how the company is scaling. SomnoMed says it restructured its North American business to include dedicated fieldbased business development representatives focused on medical education, with separate account management and customer-service teams supporting sleep dentists. That kind of organisational change signals a business trying to grow not only by improving manufacturing, but also by widening professional acceptance and referral quality.
RkJQdWJsaXNoZXIy MTE4MTQ=